Fig. 4From: Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemiaOS according to EOT MRD, and according to EOT CD4 count. (A) OS according to level of EOT MRD (for low versus intermediate, p = 0.435 and low versus high levels, p = 0.021). (B) OS according to EOT CD4 status in the whole population (p = 0.263)Back to article page